Behavioral: Duchenne Muscular Dystrophy group with Prednisone/Predisolone ( DrugBank: Prednisone )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 113 | Muscular dystrophy | 1 |
113. Muscular dystrophy
Clinical trials : 622 / Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04740554 (ClinicalTrials.gov) | March 1, 2013 | 1/2/2021 | Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy | Characterization of Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy - Influence of Corticosteroids and Betablockers | Duchenne Muscular Dystrophy | Behavioral: Duchenne Muscular Dystrophy group with Deflazacort;Behavioral: Duchenne Muscular Dystrophy group with Prednisone/Predisolone;Behavioral: Duchenne Muscular Dystrophy group without Corticosteroids therapy;Behavioral: Control Group Typically Developing | University of Sao Paulo | NULL | Completed | 11 Years | 18 Years | Male | 40 | NULL |